REFERENCES
- G.M. Brenner. Pharmacology. W.B. Saunders Co., , (2000)115.
- K.L. Clark, and L. Merkel. (2000). Potential of adenosine receptor agonists for the prevention and treatment of coronary artery diseases and acute myocardial infraction. Emerg. Drugs 5:89–108.
- A. Felsch, K. Stocker, and U. Borchard. (1994). Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacycline release in the isolated guinea-pig heart. Euro. J. Pharm. 263:261–268.
- B.B. Fredholm, A.P. Ijzerman, K.A. Jacopson, K.N. Klotz, and J. Linden. (2001). Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:527–552.
- S. Higa, C.T. Tai, Y.J. Lin, T.Y. Liu, P.C. Lee, J.L. Huang, Y. Yuniadi, B.H. Huang, M.H. Hsieh, S.H. Lee, J.Y. Kuo, K.T. Lee, and S.A. Chen. (2004). Mechanism of adenosine-induced termination of focal atrial tachycardia. J. Cardiovasc. Electrophysiol. 15 (12):1387–1393.
- S.A. Hutchinson, and P.J. Scammells. (2004). A1adenosine receptor agonist: medical chemistry and therapeutic potential. Curr. Pharm. 10:2021–2039.
- K.A. Jacobson, P.J. Galen, and M. Williams. (1992). Adenosine receptors: pharmacology, structure activity relationships, and therapeutic potential. Med. Chem. 35:407–422.
- M.J. Joosen, T.J. Bueters, and H.P. Van Helden. (2004). Cardiovascular effect of the A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning. Arch. Toxicol. 78:34–39.
- S.M. Kaiser, and R.J. Quinn. (1999). Adenosine receptors as potential therapeutic targets. Drug Discov. Today 4:542–551.
- B.G. Katzung. Basic and Clinical Pharmacology9th ed. . Appleton & Lang, New York, (2004)201–216.
- R. Nadeau. (1977). Use and mechanism of action of digitalis glycosides as anti arrhythmic drugs. Acta Cardiol. 922:97–105.
- M.G. Navarro, A.B. Auban, F.D. Moncada, and G.P. Hernandez. (1992). Role of adenosine in the digitalis action on atria-ventricular conduction in the dog heart. Arch. Inst. Cardiol. Mex. 62:409–414.
- T. Oguchi, Y. Furukawa, S. Sawaki, M. Kasama, and S. Chiba. (1995). Are negative chronotropic and inotropic responses to adenosine differentiated at the receptor or post receptor levels in isolated dog heart?. J. Pharmacol. Exp. Ther. 272:838–844.
- A. Pousti, T. Deemyad, G. Malihi, and K. Broumand. (2006). Involvement of adenosine in the effect of fluoxetine on isolated guinea-pig atria. Pharmacol. Res. 53:44–48.
- J.C. Shryock, and L. Belardinnelli. (1997). Adenosine and adenosine receptor in the cardiovascular system: biochemistry, physiology and pharmacology. Am. J. Cardial. 7 (12A):2–10.
- F. Suto, Y. Habuchi, T. Yamamoto, H. Tanaka, and K. Hamaoka. (2000). Increased sensitivity of neonate myocytes to adenosine A1 receptor stimulation in regulation of the L-type Ca2+ current. Ur. Pharmacol. 409:213–221.
- K.D. Tripathi. Essentials of Medical Pharmacology5th ed.. Paypee Prathers, New Delhi, (2003)183.
- D. Wang, and L. Belardinelli. (1994). Mechanism of negative inotropic effect of adenosine in guinea-pig atrial myocyte. Am. J. Physiol. 276:H2420–2429.